Searched for
TEVAPHARM INDIA
Fundamental Radar: Three factors seen driving 20% PAT CAGR for Marksans PharmaMarksans Pharma derives a significant portion of its sales from OTC products in the US and UK markets. It has a strong presence in these ma...- Marksans stock zooms 12% after news of Tevapharm facility buyDespite the rally, its shares have dropped 10 per cent in the last one month and the stock has tumbled 25 per cent so far in 2022
- Stocks in the news: IndusInd Bank, Adani Enterprises, Dr Reddy's, Power Grid and IT bluechipsHCL Technologies, Wipro, National Standard (India), SW Solar, NxtDigital, Mangalam Industial Finance and Artson Engineering are among the c...
- Modi government clears FDI proposals worth Rs 1,827.24 croreThe Finance Ministry today said it has cleared 12 FDI applications, including that of Ratnakar Bank to raise foreign equity limit to 74 per...
- Foreign Investment Promotion Board to consider 31 FDI proposals on FridayProposals of Tevapharm India Pvt, GMU Infosoft Pvt, U Infosoft Pvt Ltd, and Monsoon Capital LLC, US are also among these nine investment pl...
- Government to consider 31 FDI proposals on December 16The government will consider 31 foreign investment proposals, including that of Ratnakar Bank, Novartis Healthcare and HDFC Bank, on Decemb...
- India Inc's August foreign borrowings up over two-fold at $5.07 billionIndian companies had raised USD 2.31 billion from the foreign markets in the corresponding month a year ago in 2013.
Load More